Jun Sun, Min Guo, Li Chai, Siyao Xu, Yuerong Lizhu, Yuna Li, Yunyun Duan, Xiaolu Xu, Shan Lv, Jinyuan Weng, Kuncheng Li, Fuqing Zhou, Haiqing Li, Yongmei Li, Xuemei Han, Fu-Dong Shi, Xinghu Zhang, Decai Tian, Zhizheng Zhuo, Yaou Liu
Gray matter (GM) atrophies were observed in multiple sclerosis, neuromyelitis optica spectrum disorders (both anti-aquaporin-4 antibody-positive [AQP4+], and -negative [AQP4-] subtypes NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Revealing the pathogenesis of brain atrophy in these disorders would help their differential diagnosis and guide therapeutic strategies. To determine the neurobiological underpinnings of GM atrophies in multiple sclerosis, AQP4+ NMOSD, AQP4- NMOSD, and MOGAD, we conducted a virtual histology analysis that links T1-weighted image derived GM atrophy and gene expression using a multicenter cohort of 324 patients with multiple sclerosis, 197 patients with AQP4+ NMOSD, 75 patients with AQP4- NMOSD, 47 patients with MOGAD, and 2,169 healthy controls (HCs)...
May 4, 2024: Brain